PCI Biotech: Notice of Annual General Meeting 2021
May 07, 2021 06:51 ET
|
PCI Biotech Holding ASA
Oslo, Norway 7 May 2021 - The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on 28 May 2021 at 10:00am (CEST). Due to...
PCI Biotech first quarter 2021 interim results
May 07, 2021 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 7 May 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q1 2021 results. Please find enclosed the report and presentation. ...
OliX Pharmaceuticals and PCI Biotech announce a collaboration to combine OliX asiRNA and PCI Biotech fimaNAc technologies
May 05, 2021 05:00 ET
|
PCI Biotech Holding ASA
Suwon, South Korea and Oslo, Norway, May, 5th 2021 – OliX Pharmaceuticals Inc. (KOSDAQ: 226950) a leading developer of RNAi therapeutics, and PCI Biotech (OSE: PCIB), a cancer focused...
PCI Biotech: First US patient enrolled in the fimaChem pivotal RELEASE study
April 30, 2021 15:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 30 April 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced...
PCI Biotech: Invitation to first quarter 2021 results presentation
April 30, 2021 05:00 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 30 April 2021 - PCI Biotech’s (OSE: PCIB) first quarter 2021 interim report will be released on 7 May 2021 at 07.00 CEST. The interim report and presentation will be made available on...
PCI Biotech Holding ASA publishes the Annual Report 2020
April 21, 2021 03:05 ET
|
PCI Biotech Holding ASA
Oslo, Norway, April 21, 2021The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2020 and the report is attached. The Annual Report 2020 is also available on the company’s...
PCI Biotech to present at European Biotech Investor Days 2021
April 06, 2021 06:30 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 6 April 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced that...
PCI Biotech fourth quarter and preliminary full year 2020 results
February 24, 2021 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 24 February 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q4 and preliminary full year 2020 results. Please find enclosed the...
PCI Biotech: Invitation to fourth quarter 2020 results presentation
February 18, 2021 03:02 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 18 February 2021 - PCI Biotech’s (OSE: PCIB) fourth quarter and preliminary full year 2020 interim report will be released on 24 February 2021 at 07.00 CET. The interim report and...
PCI Biotech - release of the RNA Therapeutics Virtual Conference presentation
February 10, 2021 02:31 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 10 February 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today released...